Literature DB >> 17978852

Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Filippo Ansaldi1, Bianca Bruzzone, Maria Cristina Rota, Antonino Bella, Marta Ciofi degli Atti, Paolo Durando, Roberto Gasparini, Giancarlo Icardi.   

Abstract

To define the pattern of HAV infection in Italy and to study the differences among geographic areas (northern, central and southern Italy) and age-classes, we performed HAV antibody testing on sera collected in 1996-1997 from a large sample of the Italian population and compared the results with those of other seroprevalence studies and with incidence data for the period 1985-2005, calculated by a surveillance system specific for acute viral hepatitis based on symptomatic cases. A total of 3,561 sera, collected by hospital-based reference laboratories in 18 out of 20 Italian Regions, were tested; 1,138 (32%, 95% CI: 30.5-33.5) were positive. The age-adjusted prevalence was 60.1% and the age-specific rates were among the highest rates reported in Europe in the 1990s. The age-adjusted seroprevalence showed a significant north-south gradient, increasing from 55% in northern Italy to 68% in southern Italy. Age and area of residence were found to be strong predictors of previous HAV infection: the marked increase in prevalence with increasing age represents a strong cohort effect. In northern Italy, a marked increase with age was observed beginning with the 20- to 29-year age-class, whereas in southern Italy, such an increase was observed beginning with the 12- to 19-year age-class, indicating that northern Italy preceded southern Italy by 10-20 years in terms of improvements in hygiene and sanitation. The incidence of HAV infection shows an evident peak in 1997, when an outbreak occurred in southern Italy, mainly affecting 15- to 24-year-old individuals. In the period from 1998 to 2005, the incidence drastically decreased (average of 3.2/100,000 inhabitants), reaching a minimum of 2/100,000 inhabitants in 2005.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978852     DOI: 10.1007/s10654-007-9198-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  44 in total

1.  Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey.

Authors:  Beth P Bell; Deanna Kruszon-Moran; Craig N Shapiro; Stephen B Lambert; Geraldine M McQuillan; Harold S Margolis
Journal:  Vaccine       Date:  2005-12-30       Impact factor: 3.641

Review 2.  Hepatitis A.

Authors:  R S Koff
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

3.  Age-Specific Anti-Hepatitis A Virus Seroepidemiology in Italian Travelers: Indications for Anti-Hepatitis A Vaccination.

Authors: 
Journal:  J Travel Med       Date:  1996-12-01       Impact factor: 8.490

4.  Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.

Authors:  A Delem; A Safary; F De Namur; P Hauser; E D'Hondt
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

5.  Vaccination policy against hepatitis A in Italy.

Authors:  T Stroffolini; A Mele; L Sagliocca
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

6.  Seroprevalence of viral hepatitis A in the Czech Republic.

Authors:  J Beran; P Douda; R Rychlý
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

7.  Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group.

Authors:  A Mele; T Stroffolini; F Palumbo; G Gallo; P Ragni; E Balocchini; M E Tosti; R Corona; A Marzolini; A Moiraghi
Journal:  J Hepatol       Date:  1997-04       Impact factor: 25.083

8.  Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.

Authors:  W M Prodinger; C Larcher; B M Sölder; D Geissler; M P Dierich
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

9.  The role of herd immunity in an epidemic cycle of hepatitis A.

Authors:  P J Rooney; P V Coyle
Journal:  J Infect       Date:  1992-05       Impact factor: 6.072

10.  [Seroprevalence of hepatitis A in hospitalized patients in Limoges University Hospital].

Authors:  François Denis; Christian Delpeyroux; Caroline Debrock; Sylvie Rogez; Sophie Alain
Journal:  Gastroenterol Clin Biol       Date:  2003 Aug-Sep
View more
  9 in total

1.  Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh.

Authors:  Samir K Saha; Setarunnahar Saha; Salim Shakur; Mohammed Hanif; Md Ahsan Habib; Sanjoy K Datta; Hans L Bock
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

2.  Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.

Authors:  M Rapicetta; R Monarca; L A Kondili; P Chionne; E Madonna; G Madeddu; A Soddu; A Candido; S Carbonara; M S Mura; G Starnini; S Babudieri
Journal:  Infection       Date:  2012-12-22       Impact factor: 3.553

Review 3.  Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®.

Authors:  Jun-Yu Wu; Yan Liu; Jiang-Ting Chen; Ming Xia; Xiao-Mei Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

4.  Changing pattern of hepatitis a virus epidemiology in an area of high endemicity.

Authors:  Marcello Campagna; Andrea Siddu; Angelo Meloni; Claudia Basciu; Luigi Ferrai; Alessandro Pettinau; Cristiana Cardia; Giuseppina Masia; Rosa Cristina Coppola
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

5.  Seroepidemiology of hepatitis a in the croatian population.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Suncanica Ljubin-Sternak; Branko Kolaric
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

Review 6.  Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Authors:  Ziba Farajzadegan; Shervin Ghaffari Hoseini; Roya Kelishadi; Fahimeh Jamshidi; Zari Nokhodian; Rasool Noori; Parisa Mirmoghtadaee; Silva Hovsepian; Seyyed-Nassereddin Mostafavi
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

7.  Serosurveillance of hepatitis A in a region which adopted the universal mass vaccination.

Authors:  Maria Filomena Gallone; Francesco Desiante; Maria Serena Gallone; Giovanna Barbuti; Silvio Tafuri; Cinzia Germinario
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Hepatitis E virus genotype 4 outbreak, Italy, 2011.

Authors:  Anna R Garbuglia; Paola Scognamiglio; Nicola Petrosillo; Claudio Maria Mastroianni; Pasquale Sordillo; Daniele Gentile; Patrizia La Scala; Enrico Girardi; Maria R Capobianchi
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

9.  Pattern of Hepatitis A Virus Epidemiology in Nursing Students and Adherence to Preventive Measures at Two Training Wards of a University Hospital.

Authors:  Marcello Campagna; Noemi Maria Mereu; Lucia Mulas; Roberta Pilia; Maria Francesca Piazza; Laura Spada; Alberto Lai; Igor Portoghese; Maura Galletta; Giuseppina Masia; Angelo Restivo; Paolo Mura; Gabriele Finco; Rosa Cristina Coppola
Journal:  Hepat Mon       Date:  2016-02-27       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.